As of 2026-07-09, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 17.3x | 16.0x |
| Forward P/E multiples | 15.0x - 21.5x | 18.0x |
| Fair Price | (10.52) - (12.05) | (11.86) |
| Upside | -247.1% - -268.6% | -265.9% |
| Date | EV/EBITDA |